Table 2. Crystallization conditions observed for RelTt NTD .
Conditions shown in bold yielded the crystals that were used for data collection.
| Enzyme | Condition | Temperature (K) | Cryoprotectant |
|---|---|---|---|
| RelTt NTD | Morpheus II B11 | 20 | — |
| RelTt NTD | Morpheus II C10 | 20 | — |
| RelTt NTD | Morpheus II C11 | 20 | — |
| RelTt NTD | Morpheus II E10 | 20 | — |
| RelTt NTD | Morpheus II F10 | 20 | — |
| RelTt NTD | Morpheus II G6 | 20 | — |
| RelTt NTD | Morpheus II G10 | 20 | — |
| RelTt NTD | Morpheus II H11 | 20 | — |
| RelTt NTD | PACT premier E4 | 20 | PEG 400 |
| RelTtNTD | PACT premier G2 | 20 | PEG 400 |
| RelTt NTD | PACT premier G3 | 20 | 25% MPD, 20% glycerol, 1 M TMAO |
| RelTt NTD | PACT premier H4 | 20 | 20% glycerol |
| RelTtNTD + APPNP | PACT premier D12 | 20 | 3 M TMAO |
| RelTt NTD + APPNP | PACT premier G5 | 20 | 3 M TMAO, 20% glycerol, PEG 400 |
| RelTt NTD + APPNP | PACT premier G10 | 20 | 1.5 M TMAO, 20% glycerol, 50 mM APPNP, 50 mM GDP, PEG 400 |
| RelTt NTD + GDP | Morpheus II G5 | 20 | — |
| RelTt NTD + GDP | Morpheus II G6 | 20 | — |
| RelTtNTD | Morpheus II G8 | 4 | — |